Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today...
Axcelis Announces Participation in SEMICON Korea 2024
BEVERLY, Mass., Jan. 22, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform...
Hitachi-LG Data Storage to Sell SK hynix Heat Sink for PlayStation 5 with Exclusive Promotion
SEOUL, South Korea, Jan. 22, 2024 /PRNewswire/ -- January 22, Hitachi-LG Data Storage Inc., SK hynix's global distributor and manufacturing partner, is set to launch the new "Haechi H01" heat sink designed specifically for the PlayStation 5. This...
Dell Unveils Innovative Loyalty Program in Japan with OORT
NEW YORK, Jan. 21, 2024 /PRNewswire/ -- Dell Technologies has announced the expansion of its latest global loyalty program to Japan on Jan 18, 2024, following successful launches in Canada and the United States in 2023. In a significant move for the...
Trip.com Group at World Economic Forum 2024: revealing Asia's biggest untapped opportunities in tourism
Asian destinations and attractions among most booked; growing demand for event and sustainable travel CEO shares Asia's untapped opportunities and investment potential, highlights positive visa policies and visitor numbers Asia's growth prospects...
Sanyou Super Trillion Peptide Molecule Discovery Platform Officially Launched Today
SHANGHAI, Jan. 20, 2024 /PRNewswire/ -- On January 13, 2024 local time, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. officially announced the launch of its "Sanyou Super Trillion Peptide Molecule Discovery Platform". The Sanyou Super Trillion...
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI
BEIJING and SAN FRANCISCO, Jan. 20, 2024 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK), a clinical-stage oncology company focusing on undruggable targets, announced data of glecirasib in patients with pancreatic cancer and other solid tumors in...
The House of Angostura® kicks off the countdown to its bicentennial celebrations.
PORT OF SPAIN, Trinidad, Jan. 20, 2024 /PRNewswire/ -- The House of Angostura® prepares to celebrate as it counts down to its 200-year anniversary in 2024. With just a few weeks into the start of the new year, the House of Angostura® is ramping up...